Blog | March 27, 2014

Breast Density, Screening Controversies Discussed at NCoBC

The 24th Annual Interdisciplinary Breast Center Conference (NCoBC 2014), sponsored by the National Consortium of Breast Centers (NCBC), was held March 15-19 at Caesars Palace in Las Vegas. Each year, NCBC brings together medical and industry professionals from around the globe to network, learn, and share ideas, methodologies and treatment options that improve quality of care and outcome for patients diagnosed with breast diseases.

At this year’s conference, ITN’s publisher Sean Reilly had the opportunity to discuss the many current trends in this field with leading industry experts including Gary Levine, M.D., president of NCBC, and Nancy Cappello, founder/director of Are You Dense, Inc. His videotaped interviews can be found at the links below:

·      Highlights of the 2014 NCoBC Meeting: Screening Controversy: Gary Levine, M.D., president of the National Consortium of Breast Centers, reacts to the recent Canadian study's questioning the value of preventative mammography screening and the confusion it has caused.

·      Highlights of the 2014 NCoBC Meeting: Breast Density Discussion: Gary Levine, M.D., president of the National Consortium of Breast Centers, discusses breast density, alternative screening technologies and the impact of "Inform Law" on clinical workflow.

·      Highlights of the 2014 NCoBC Meeting: Personalized Breast Screening: Gary Levine, M.D., president of the National Consortium of Breast Centers, predicts a future of personalized breast screening and addresses related challenges that will need to be addressed for successful implementation.

·      Highlights of the 2014 NCoBC Meeting: Gary Levine, M.D., president of the National Consortium of Breast Centers, discusses highlights of the NCoBC conference and NCBC’s mission for 2014.

·      Nancy Cappello Discusses Are You Dense Advocacy at NCoBC 2014: Nancy Cappello, founder/director of Are You Dense, Inc., discusses breast density, “Inform Law” and her mission to expand screening options for women. 

In addition, some of the products that were displayed at the conference in the exhibit hall are featured below. 


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now